- Investing Ideas
- /
- Swiss Large Cap High Growth Potential
Swiss Large Cap High Growth Potential
UPDATED Oct 01, 2022
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
16 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIFNVifor Pharma | CHF178.85 | 1.9% | 48.9% | CHF11.6b | CHF153.50 | PE79.2x | E42.3% | 1.1% | Pharmaceuticals & Biotech | ||
| STMNStraumann Holding | CHF91.84 | 3.3% | -45.6% | CHF14.6b | CHF141.61 | PE30x | E11.8% | 0.7% | Healthcare | ||
| SOONSonova Holding | CHF220.00 | 2.8% | -37.7% | CHF13.5b | CHF335.00 | PE20.7x | E10.5% | 2.0% | Healthcare | ||
| CSGNCredit Suisse Group | CHF3.98 | -2.3% | -56.7% | CHF10.4b | CHF6.16 | PB0.2x | E86.1% | 2.5% | Diversified Financials | ||
| ALCAlcon | CHF58.14 | -0.3% | -21.6% | CHF28.6b | CHF81.34 | PE63.7x | E26.3% | 0.3% | Healthcare | ||
| ABBNABB | CHF25.80 | 2.4% | -15.7% | CHF48.8b | CHF32.33 | PE11.5x | E9.0% | 3.1% | Capital Goods | ||
| GIVNGivaudan | CHF3,003.00 | 2.0% | -29.9% | CHF27.7b | CHF3,443.06 | PE35.5x | E10.5% | 2.2% | Materials | ||
| PGHNPartners Group Holding | CHF804.60 | 1.2% | -43.9% | CHF21.0b | CHF1,255.67 | PE16.2x | E13.1% | 4.1% | Diversified Financials | ||
| SRENSwiss Re | CHF73.16 | -3.9% | -8.3% | CHF21.1b | CHF88.17 | PE39.3x | E30.8% | 7.9% | Insurance | ||
| BARNBarry Callebaut | CHF1,869.00 | -0.3% | -11.4% | CHF10.2b | CHF2,404.82 | PE25.4x | E10.3% | 1.5% | Food, Beverage & Tobacco | ||
| UHRSwatch Group | CHF224.50 | -0.09% | -8.7% | CHF11.3b | CHF281.86 | PE14.4x | E9.1% | 2.4% | Consumer Durables | ||
| EMSNEMS-CHEMIE HOLDING | CHF628.50 | 3.1% | -28.4% | CHF14.7b | CHF902.29 | PE26.4x | E8.5% | 3.3% | Materials | ||
| CFRCompagnie Financière Richemont | CHF94.28 | -2.0% | -4.8% | CHF53.8b | CHF131.10 | PE27x | E16.6% | 2.2% | Consumer Durables | ||
| LONNLonza Group | CHF486.30 | 9.5% | -30.0% | CHF36.1b | CHF718.38 | PE39.7x | E16.9% | 0.6% | Pharmaceuticals & Biotech | ||
| SGSNSGS | CHF2,125.00 | 1.0% | -21.8% | CHF15.9b | CHF2,448.90 | PE25.8x | E8.0% | 3.8% | Commercial Services | ||
| SIKASika | CHF200.70 | 2.3% | -31.9% | CHF30.8b | CHF301.28 | PE26.8x | E15.1% | 1.4% | Materials |
Page 1 of 1